| Dr Jane K Dorval, MD | |
|
1 Medical Center Blvd, Chester, PA 19013-3902 | |
| (610) 874-2501 | |
| (610) 447-6776 |
| Full Name | Dr Jane K Dorval |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 1 Medical Center Blvd, Chester, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700923794 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD020606E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jane K Dorval, MD 309 Country Club Dr, Lansdale, PA 19446-1462 Ph: () - | Dr Jane K Dorval, MD 1 Medical Center Blvd, Chester, PA 19013-3902 Ph: (610) 874-2501 |
News Archive
Aileron Therapeutics and Roche announced today that they have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Peptide Therapeutics. As part of this agreement, Roche will work with Aileron to develop drug candidates against up to five undisclosed targets selected from Roche's key therapeutic areas, which include oncology, virology, inflammation, metabolism and CNS.
A new pilot study in Parkinson's disease suggests a new era of clinical research which removes the barrier of distance for both scientists and volunteers. The research, which appears in the journal Digital Health, could also enable researchers to leverage the rapid growth in personal genetic testing to better diagnose, and potentially treat, a wide range of diseases.
Genentech, a member of the Roche Group, today announced the company will present results from studies of its investigational medicine pertuzumab in HER2-positive breast cancer at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium December 6-10.
According to a new study some doctors apparently consider it perfectly acceptable to withhold information regarding issues such as birth control, abortion and sedating dying patients, and even more of the medical profession feel under no obligation to tell patients where or how they access such advice or care.
Obese rhesus monkeys lost on average 11 percent of their body weight after four weeks of treatment with an experimental drug that selectively destroys the blood supply of fat tissue, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Science Translational Medicine.
› Verified 1 days ago
Dr. Jyothi Chinta, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Blvd, Chester, PA 19013 Phone: 610-874-2501 Fax: 610-874-2946 | |
Mr. William Neal Miller, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1 East Beacon Light Lane, Suite B, Chester, PA 19013 Phone: 610-490-3900 Fax: 610-490-3912 |